BDP-13176

CAS No. 2290660-61-4

BDP-13176 ( —— )

Catalog No. M24042 CAS No. 2290660-61-4

BDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 201 In Stock
10MG 323 In Stock
25MG 552 In Stock
50MG 785 In Stock
100MG 1062 In Stock
500MG 2142 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BDP-13176
  • Note
    Research use only, not for human use.
  • Brief Description
    BDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.
  • Description
    BDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    fascin 1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2290660-61-4
  • Formula Weight
    497.4
  • Molecular Formula
    C24H22Cl2N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (251.32 mM; Need ultrasonic)
  • SMILES
    O=C(NC1=CC=NC=C1)C(C2=C3C=NN2C4CCNCC4)=CN(CC5=CC=C(Cl)C(Cl)=C5)C3=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Francis S, et al. Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents. Bioorg Med Chem Lett. 2019;29(8):1023-1029.
molnova catalog
related products
  • 2-Iodobenzoic acid

    2-Iodobenzoic acid is the impact-sensitive intermediate in the synthesis of the Dess-Martin periodinane.

  • Thymulin

    Thymulin is a peptide hormone which is mainly produced by thymic epithelial cells and it has immune-modulatory and anti-inflammatory effects.

  • Bonducellin

    Bonducellin has anti-inflammatory activities, it can significantly and dose-dependently inhibit the inflammatory mediators; nitric oxide (NO), and cytokines [tumor necrosis factor (TNF)-alpha and interleukin (IL)-12.